Renal Disease in Older Adults

Living reference work entry


Renal disease is common in older adults, and it is an important factor to consider in the surgical patient. Of particular concern is the fact that the perioperative period creates significant vulnerabilities to a number of organ systems, and renal disease can often magnify these risks. In addition, de novo injury to the kidneys is a common event in the perioperative period, and it is important that preventive measures are in place to reduce or minimize these events. This chapter reviews the unique management challenges associated with surgery in older adults with renal disease, including the importance of identifying specific sequelae that can present as a result of renal dysfunction and methods to optimize risk during the perioperative period.


  1. 1.
    Glassock RJ, Winearls C (2009) Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc 120:419–428PubMedPubMedCentralGoogle Scholar
  2. 2.
    Coresh J et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298(17):2038–2047CrossRefGoogle Scholar
  3. 3.
    Kagoma YK et al (2011) Impact of estimated GFR reporting on patients, clinicians, and health-care systems: a systematic review. Am J Kidney Dis 57(4):592–601CrossRefGoogle Scholar
  4. 4.
    Cleland JG, Coletta A, Witte K (2006) Practical applications of intravenous diuretic therapy in decompensated heart failure. Am J Med 119(12 Suppl 1):S26–S36CrossRefGoogle Scholar
  5. 5.
    Brater DC (1998) Diuretic therapy. N Engl J Med 339(6):387–395CrossRefGoogle Scholar
  6. 6.
    Hoorn EJ, Ellison DH (2017) Diuretic resistance. Am J Kidney Dis 69(1):136–142CrossRefGoogle Scholar
  7. 7.
    Valika A, Peixoto AJ (2016) Hypertension management in transition: from CKD to ESRD. Adv Chronic Kidney Dis 23(4):255–261CrossRefGoogle Scholar
  8. 8.
    Muntner P et al (2010) Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis 55(3):441–451CrossRefGoogle Scholar
  9. 9.
    Lazarus JM, Hampers C, Merrill JP (1974) Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy. Arch Intern Med 133(6):1059–1066CrossRefGoogle Scholar
  10. 10.
    Schalekamp MA et al (1973) Hypertension in chronic renal failure. An abnormal relation between sodium and the renin-angiotensin system. Am J Med 55(3):379–390CrossRefGoogle Scholar
  11. 11.
    Yamout H, Lazich I, Bakris GL (2014) Blood pressure, hypertension, RAAS blockade, and drug therapy in diabetic kidney disease. Adv Chronic Kidney Dis 21(3):281–286CrossRefGoogle Scholar
  12. 12.
    Benedetto U et al (2008) Preoperative angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting. Ann Thorac Surg 86(4):1160–1165CrossRefGoogle Scholar
  13. 13.
    Arora P et al (2008) Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol 3(5):1266–1273CrossRefGoogle Scholar
  14. 14.
    Drenger B et al (2012) Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: effects on in-hospital morbidity and mortality. Circulation 126(3):261–269CrossRefGoogle Scholar
  15. 15.
    Benedetto U et al (2008) Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery. J Cardiovasc Med (Hagerstown) 9(11):1098–1103CrossRefGoogle Scholar
  16. 16.
    Oster JR, Singer I, Fishman LM (1995) Heparin-induced aldosterone suppression and hyperkalemia. Am J Med 98(6):575–586CrossRefGoogle Scholar
  17. 17.
    Martyn JA, Richtsfeld M (2006) Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology 104(1):158–169CrossRefGoogle Scholar
  18. 18.
    Ettinger PO, Regan TJ, Oldewurtel HA (1974) Hyperkalemia, cardiac conduction, and the electrocardiogram: a review. Am Heart J 88(3):360–371CrossRefGoogle Scholar
  19. 19.
    Scherr L et al (1961) Management of hyperkalemia with a cation-exchange resin. N Engl J Med 264:115–119CrossRefGoogle Scholar
  20. 20.
    Dhondup T, Qian Q (2017) Electrolyte and acid-base disorders in chronic kidney disease and end-stage kidney failure. Blood Purif 43(1–3):179–188CrossRefGoogle Scholar
  21. 21.
    Carmichael P, Carmichael AR (2003) Acute renal failure in the surgical setting. ANZ J Surg 73(3):144–153CrossRefGoogle Scholar
  22. 22.
    Lagny MG et al (2015) Incidence and outcomes of acute kidney injury after cardiac surgery using either criteria of the RIFLE classification. BMC Nephrol 16:76CrossRefGoogle Scholar
  23. 23.
    Vandenberghe W, De Loor J, Hoste EA (2017) Diagnosis of cardiac surgery-associated acute kidney injury from functional to damage biomarkers. Curr Opin Anaesthesiol 30(1):66–75PubMedGoogle Scholar
  24. 24.
    Parikh CR et al (2011) Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol 22(9):1737–1747CrossRefGoogle Scholar
  25. 25.
    Parikh CR et al (2011) Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 22(9):1748–1757CrossRefGoogle Scholar
  26. 26.
    Meersch M et al (2014) Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS One 9(3):e93460CrossRefGoogle Scholar
  27. 27.
    Lameire N et al (1987) Causes and prognosis of acute renal failure in elderly patients. Nephrol Dial Transplant 2(5):316–322PubMedGoogle Scholar
  28. 28.
    Abelha FJ et al (2009) Determinants of postoperative acute kidney injury. Crit Care 13(3):R79CrossRefGoogle Scholar
  29. 29.
    Kusaka J et al (2012) Age-dependent responses to renal ischemia-reperfusion injury. J Surg Res 172(1):153–158CrossRefGoogle Scholar
  30. 30.
    Schmitt R, Cantley LG (2008) The impact of aging on kidney repair. Am J Physiol Ren Physiol 294(6):F1265–F1272CrossRefGoogle Scholar
  31. 31.
    Sun LY et al (2015) Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery. Anesthesiology 123(3):515–523CrossRefGoogle Scholar
  32. 32.
    Prowle JR et al (2010) Fluid balance and acute kidney injury. Nat Rev Nephrol 6(2):107–115CrossRefGoogle Scholar
  33. 33.
    Heung M et al (2012) Fluid overload at initiation of renal replacement therapy is associated with lack of renal recovery in patients with acute kidney injury. Nephrol Dial Transplant 27(3):956–961CrossRefGoogle Scholar
  34. 34.
    Prowle JR et al (2012) Clinical review: volume of fluid resuscitation and the incidence of acute kidney injury – a systematic review. Crit Care 16(4):230CrossRefGoogle Scholar
  35. 35.
    Finfer S et al (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350(22):2247–2256CrossRefGoogle Scholar
  36. 36.
    Zarychanski R et al (2013) Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 309(7):678–688CrossRefGoogle Scholar
  37. 37.
    Opperer M et al (2015) Use of perioperative hydroxyethyl starch 6% and albumin 5% in elective joint arthroplasty and association with adverse outcomes: a retrospective population based analysis. BMJ 350:h1567CrossRefGoogle Scholar
  38. 38.
    Redfors B et al (2011) Effects of norepinephrine on renal perfusion, filtration and oxygenation in vasodilatory shock and acute kidney injury. Intensive Care Med 37(1):60–67CrossRefGoogle Scholar
  39. 39.
    Luk L, Steinman J, Newhouse JH (2017) Intravenous contrast-induced nephropathy – the rise and fall of a threatening idea. Adv Chronic Kidney Dis 24(3):169–175CrossRefGoogle Scholar
  40. 40.
    Parfrey PS et al (1989) Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 320(3):143–149CrossRefGoogle Scholar
  41. 41.
    Davidson CJ et al (1989) Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med 110(2):119–124CrossRefGoogle Scholar
  42. 42.
    Barrett BJ (1994) Contrast nephrotoxicity. J Am Soc Nephrol 5(2):125–137PubMedGoogle Scholar
  43. 43.
    Sato A et al (2015) Effect of the Mehran risk score for the prediction of clinical outcomes after percutaneous coronary intervention. J Cardiol 66(5):417–422CrossRefGoogle Scholar
  44. 44.
    Detrenis S et al (2005) Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art. Nephrol Dial Transplant 20(8):1542–1550CrossRefGoogle Scholar
  45. 45.
    Persson PB, Hansell P, Liss P (2005) Pathophysiology of contrast medium-induced nephropathy. Kidney Int 68(1):14–22CrossRefGoogle Scholar
  46. 46.
    Jurado-Roman A et al (2015) Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention. Am J Cardiol 115(9):1174–1178CrossRefGoogle Scholar
  47. 47.
    Luo Y et al (2014) Remedial hydration reduces the incidence of contrast-induced nephropathy and short-term adverse events in patients with ST-segment elevation myocardial infarction: a single-center, randomized trial. Intern Med 53(20):2265–2272CrossRefGoogle Scholar
  48. 48.
    Brar SS et al (2014) Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial. Lancet 383(9931):1814–1823CrossRefGoogle Scholar
  49. 49.
    Briguori C et al (2011) Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design. EuroIntervention 6(9):1117–1122, 7CrossRefGoogle Scholar
  50. 50.
    Investigators ACT (2011) Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized acetylcysteine for contrast-induced nephropathy trial (ACT). Circulation 124(11):1250–1259CrossRefGoogle Scholar
  51. 51.
    Gajdos C et al (2013) Risk of major nonemergent inpatient general surgical procedures in patients on long-term dialysis. JAMA Surg 148(2):137–143CrossRefGoogle Scholar
  52. 52.
    Parikh DS et al (2010) Perioperative outcomes among patients with end-stage renal disease following coronary artery bypass surgery in the USA. Nephrol Dial Transplant 25(7):2275–2283CrossRefGoogle Scholar
  53. 53.
    Yuo TH et al (2014) Limited survival in dialysis patients undergoing intact abdominal aortic aneurysm repair. J Vasc Surg 60(4):908–13.e1CrossRefGoogle Scholar
  54. 54.
    Schermerhorn ML et al (2008) Endovascular vs. open repair of abdominal aortic aneurysms in the Medicare population. N Engl J Med 358(5):464–474CrossRefGoogle Scholar
  55. 55.
    Moist LM et al (2008) Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian organ replacement registry 2001–2004. Clin J Am Soc Nephrol 3(6):1726–1732CrossRefGoogle Scholar
  56. 56.
    Pisoni RL et al (2009) Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis 53(3):475–491CrossRefGoogle Scholar
  57. 57.
    Hod T et al (2014) Factors predicting failure of AV “fistula first” policy in the elderly. Hemodial Int 18(2):507–515CrossRefGoogle Scholar

Authors and Affiliations

  1. 1.Yale School of MedicineNew HavenUSA
  2. 2.Montefier Medical Center/Albert Einstein College of MedicineNew YorkUSA

Section editors and affiliations

  • Marcia McGory Russell
    • 1
  • Zara Cooper
    • 2
  1. 1.Department of SurgeryDavid Geffen School of Medicine at the University of CaliforniaLos AngelesUSA
  2. 2.Ariadne LabsBostonUSA

Personalised recommendations